PlainDoctor

2026 NPPES data Endocrinology, Diabetes & Metabolism Physician NPI 1457354581 M.D.
Verify on CMS →

Arvind Cavale, M.D.

Endocrinology, Diabetes & Metabolism Physician in Feasterville Trevose, Pennsylvania.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 7,852 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
7K
Medicare Part D claims · 665 beneficiaries · Endocrinology, Diabetes & Metabolism Physician avg: 3K
Generic prescribing
50%
generic claims · 44% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
▼ 8 pts below national avg 83.1 · Above neutral
Industry payments
$40.43
2 payments · CMS Open Payments (Sunshine Act)
Verify NPI on CMS Methodology
Compiled from official public sources by the PlainDoctor editorial team.

What the federal data shows

Arvind Cavale, M.D. reported a CMS MIPS final score of 75/100 - below the 83.1 national average - and filed 7,021 Medicare Part D claims in 2023.

75/100
MIPS score · -8 vs avg
7K
Part D claims, 2023
50%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Arvind Cavale, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure

75 15th percentile higher than 15% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). This entry sits in this band. 80–90: 129,887 scored providers (27%). Above this entry. 90+: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Where Arvind Cavale, M.D. sits

This provider among endocrinology, diabetes & metabolism physician peers

Across the 2,521 endocrinology, diabetes & metabolism physician providers who report both Medicare Part D prescribing and a MIPS quality score, Arvind Cavale, M.D. writes more Part D claims than 91% of them and scores higher on MIPS quality than 15% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.

Part D claim volume vs MIPS quality, by specialty percentile

Lower volume · High qualityHigh volume · High qualityLower volume · Lower qualityHigh volume · Lower quality02550751000255075100Part D claim volume, percentile in specialtyMIPS quality, percentilePart D claim volume, percentile in specialty: 40 · MIPS quality, percentile: 80Part D claim volume, percentile in specialty: 57 · MIPS quality, percentile: 77Part D claim volume, percentile in specialty: 63 · MIPS quality, percentile: 72Part D claim volume, percentile in specialty: 77 · MIPS quality, percentile: 48Part D claim volume, percentile in specialty: 25 · MIPS quality, percentile: 58Part D claim volume, percentile in specialty: 13 · MIPS quality, percentile: 12Part D claim volume, percentile in specialty: 47 · MIPS quality, percentile: 63Part D claim volume, percentile in specialty: 28 · MIPS quality, percentile: 32Part D claim volume, percentile in specialty: 2 · MIPS quality, percentile: 48Part D claim volume, percentile in specialty: 7 · MIPS quality, percentile: 95Part D claim volume, percentile in specialty: 95 · MIPS quality, percentile: 12Part D claim volume, percentile in specialty: 10 · MIPS quality, percentile: 32Part D claim volume, percentile in specialty: 80 · MIPS quality, percentile: 40Part D claim volume, percentile in specialty: 93 · MIPS quality, percentile: 68Part D claim volume, percentile in specialty: 17 · MIPS quality, percentile: 87Part D claim volume, percentile in specialty: 42 · MIPS quality, percentile: 0Part D claim volume, percentile in specialty: 58 · MIPS quality, percentile: 43Part D claim volume, percentile in specialty: 30 · MIPS quality, percentile: 55Part D claim volume, percentile in specialty: 55 · MIPS quality, percentile: 12Part D claim volume, percentile in specialty: 83 · MIPS quality, percentile: 78Part D claim volume, percentile in specialty: 20 · MIPS quality, percentile: 8Part D claim volume, percentile in specialty: 18 · MIPS quality, percentile: 92Part D claim volume, percentile in specialty: 97 · MIPS quality, percentile: 12Part D claim volume, percentile in specialty: 0 · MIPS quality, percentile: 98Part D claim volume, percentile in specialty: 43 · MIPS quality, percentile: 7Part D claim volume, percentile in specialty: 78 · MIPS quality, percentile: 30Part D claim volume, percentile in specialty: 12 · MIPS quality, percentile: 98Part D claim volume, percentile in specialty: 87 · MIPS quality, percentile: 70Part D claim volume, percentile in specialty: 37 · MIPS quality, percentile: 12Part D claim volume, percentile in specialty: 23 · MIPS quality, percentile: 93Part D claim volume, percentile in specialty: 45 · MIPS quality, percentile: 90Part D claim volume, percentile in specialty: 82 · MIPS quality, percentile: 12Part D claim volume, percentile in specialty: 32 · MIPS quality, percentile: 3Part D claim volume, percentile in specialty: 48 · MIPS quality, percentile: 65Part D claim volume, percentile in specialty: 3 · MIPS quality, percentile: 28Part D claim volume, percentile in specialty: 35 · MIPS quality, percentile: 2Part D claim volume, percentile in specialty: 75 · MIPS quality, percentile: 12Part D claim volume, percentile in specialty: 50 · MIPS quality, percentile: 57Part D claim volume, percentile in specialty: 22 · MIPS quality, percentile: 60Part D claim volume, percentile in specialty: 73 · MIPS quality, percentile: 42Part D claim volume, percentile in specialty: 52 · MIPS quality, percentile: 75Part D claim volume, percentile in specialty: 53 · MIPS quality, percentile: 53Part D claim volume, percentile in specialty: 68 · MIPS quality, percentile: 12Part D claim volume, percentile in specialty: 33 · MIPS quality, percentile: 83Part D claim volume, percentile in specialty: 27 · MIPS quality, percentile: 47Part D claim volume, percentile in specialty: 98 · MIPS quality, percentile: 62Part D claim volume, percentile in specialty: 67 · MIPS quality, percentile: 83Part D claim volume, percentile in specialty: 85 · MIPS quality, percentile: 73Part D claim volume, percentile in specialty: 8 · MIPS quality, percentile: 10Part D claim volume, percentile in specialty: 100 · MIPS quality, percentile: 97Part D claim volume, percentile in specialty: 88 · MIPS quality, percentile: 37Part D claim volume, percentile in specialty: 38 · MIPS quality, percentile: 67Part D claim volume, percentile in specialty: 5 · MIPS quality, percentile: 45Part D claim volume, percentile in specialty: 72 · MIPS quality, percentile: 12Part D claim volume, percentile in specialty: 62 · MIPS quality, percentile: 35Part D claim volume, percentile in specialty: 65 · MIPS quality, percentile: 80Part D claim volume, percentile in specialty: 90 · MIPS quality, percentile: 5Part D claim volume, percentile in specialty: 60 · MIPS quality, percentile: 38Part D claim volume, percentile in specialty: 15 · MIPS quality, percentile: 88Part D claim volume, percentile in specialty: 70 · MIPS quality, percentile: 52Arvind Cavale, M.D.-Part D claim volume, percentile in specialty: 91 · MIPS quality, percentile: 15
Part D claim volume vs MIPS quality, by specialty percentile

Each dot is one endocrinology, diabetes & metabolism physician peer from a representative sample of 60; the gold marker is Arvind Cavale, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.

✓
Board certification likely (heuristic, not verified)

Arvind Cavale, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Arvind Cavale, M.D.?

Below national average

NPI registry status

Active

Issued 05/23/2005

NPI 1457354581

Primary specialty

Endocrinology, Diabetes & Metabolism Physician

Mid-sized

7,852 US NPIs in this specialty

Medicare Part D claims

7,021 166% vs specialty avg

2023 prescription claims

Specialty avg: 2,639

MIPS final score

75/100 8.1 pts vs avg

Above neutral band

vs 83.1 national avg

Specialty distribution in Pennsylvania

How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Pennsylvania providers

Pennsylvania providers
Student in an Organized Health Care Education/Training Program - 5.6%Student in an Organized Health Care Education/Training Program5.6%Pharmacist - 5%Pharmacist5%Physical Therapist - 4.9%Physical Therapist4.9%Mental Health Counselor - 3.9%Mental Health Counselor3.9%Internal Medicine Physician - 3.3%Internal Medicine Physician3.3%Professional Counselor - 3.2%Professional Counselor3.2%Endocrinology, Diabetes & Metabolism Physician - 0.1%Endocrinology, Diabetes & Metabolism Physician0.1%
Largest specialties in Pennsylvania (% of in-state providers)

Medicare quality performance, MIPS

Arvind Cavale, M.D.'s 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average

Below national average
MIPS Final Score
75/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Endocrinology, Diabetes & Metabolism Physician) - 75/100 vs national avg 83.1

0%100%National avg83%75%
MIPS final score (Endocrinology, Diabetes & Metabolism Physician) - 75/100 vs national avg 83.1
How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Arvind Cavale, M.D. appears in the CMS NPPES registry as a Endocrinology, Diabetes & Metabolism Physician provider holding M.D. credentials at 4 ROSE AVE, Feasterville Trevose, PA, 19053, with a listed phone of (215) 953-6804. NPI 1457354581 was issued on 05/23/2005.

Medicare Part D records for calendar year 2023 show 7,021 prescription claims written by this provider, covering 665 Medicare beneficiaries and totaling roughly $3.3 million in drug spend, split 44% brand-name and 50% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 75/100 for the 2023 performance year, compared with the national average of 83.1.

Endocrinology, Diabetes & Metabolism Physician is a mid-sized specialty nationwide, with 7,852 enrolled providers across 54 states and an average of 2,639 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.

Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

4 ROSE AVE
Feasterville Trevose, PA 19053
(215) 953-6804

Provider Details

NPI 1457354581
Specialty Endocrinology, Diabetes & Metabolism Physician
Credentials M.D.
Gender Male
NPI Issued 05/23/2005

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

75
Final Score
Avg: 83.1

Reporting: Individual

Hospital and facility affiliations

Facilities where Arvind Cavale, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

Diabetes And Endocrinology Consultants OF Pennsylvania LLC
Feasterville Trevose, PA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Arvind Cavale, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$40

Largest payer

Alexion Pharmaceuticals, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context - Pennsylvania PA-BOM 2023 annual report

Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~45K Pennsylvania medical licensees in 2023 - they are NOT specific to Arvind Cavale, M.D.. To verify Arvind Cavale, M.D.'s current license status, search the PA-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

133
Total board actions, Pennsylvania 2023
Across 129 cases
2.96
Actions per 1,000 licensees
Pennsylvania statewide rate
probation
Most common action type
48 cases

PA-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Pennsylvania disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

Arvind Cavale, M.D. - brand share 44.0%
Endocrinology, Diabetes & Metabolism Physician average

44% brand-name claims vs 50% generic, on 7,021 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

7,021
Total Claims
$3.3M
Total Drug Cost
665
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
17,317
Total Day Supply
517,477
Brand vs Generic
44% brand / 50% generic
Brand Drug Cost
$3.0M
Generic Drug Cost
$142K

Patient Demographics

Average Patient Age
72.6 years
Avg HCC Risk Score
1.35
Gender Split
55% female / 45% male
Age Distribution
<65: 54, 65-74: 364, 75-84: 203, 85+: 44

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What Arvind Cavale, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Levothyroxine Sodium
 881
Repaglinide
 570
Trulicity
Dulaglutide
347
Rosuvastatin Calcium
 328
Metformin Hcl
 291
Novolog Flexpen
Insulin Aspart
282
Synthroid
Levothyroxine Sodium
273
Trijardy Xr
Empaglifloz/Linaglip/Metformin
195
Mounjaro
Tirzepatide
137
Synjardy
Empagliflozin/Metformin Hcl
135

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

More Endocrinology, Diabetes & Metabolism Physician in PA → All providers in Pennsylvania → Compare specialties →

Endocrinology, Diabetes & Metabolism Physician Overview

How Arvind Cavale, M.D. fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.

7,852
Endocrinology, Diabetes & Metabolism Physician Providers in US
54
States with Endocrinology, Diabetes & Metabolism Physician
2,639
Avg Claims per Provider

Arvind Cavale, M.D.'s 7,021 claims are above the specialty average of 2,639.

Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Pennsylvania

Other clinicians with the same primary specialty enrolled in Pennsylvania, drawn from the same CMS NPPES roster as Cavale.

Dr. Munira Abbasi
MD
Pittsburgh, PA
Dr. Jana Abraham
MD
Berwyn, PA
Dr. Rachel Abramczyk
DO
Parkesburg, PA
Dr. Michael Adler
M.D.
Lewisburg, PA
Shivani Agarwal
Philadelphia, PA

Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the Pennsylvania medical board, federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Endocrinology, Diabetes & Metabolism Physician peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Healthcare Guides

Learn more about finding, verifying, and understanding healthcare providers.

How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026

Explore Pennsylvania

Providers in Pennsylvania
Browse all specialties and cities
All Specialties
690+ healthcare specialties
Rankings
Top prescribers and providers by state

Frequently Asked Questions

What is Arvind Cavale, M.D.'s specialty? ▼
Arvind Cavale, M.D. specializes in Endocrinology, Diabetes & Metabolism Physician and practices in Feasterville Trevose, Pennsylvania. Credentials: M.D..
How much does Arvind Cavale, M.D. prescribe under Medicare Part D? ▼
In 2023, Arvind Cavale, M.D. wrote 7,021 Medicare Part D claims totaling $3.3M in drug costs for 665 beneficiaries.
What is Arvind Cavale, M.D.'s Medicare quality score? ▼
Arvind Cavale, M.D. has a CMS MIPS Final Score of 75/100. The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Arvind Cavale, M.D. located? ▼
Arvind Cavale, M.D. is located at 4 ROSE AVE, Feasterville Trevose, PA, 19053. Phone: (215) 953-6804.
What is Arvind Cavale, M.D.'s NPI number? ▼
Arvind Cavale, M.D.'s National Provider Identifier (NPI) is 1457354581, issued on 05/23/2005.
Does Arvind Cavale, M.D. prescribe more brand-name or generic drugs? ▼
Arvind Cavale, M.D.'s prescribing is 44% brand-name and 50% generic drugs by claim count, with $3.0M in brand drug costs.
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
There are 7,852 Endocrinology, Diabetes & Metabolism Physician providers across 54 states in the US. The average Endocrinology, Diabetes & Metabolism Physician provider writes 2,639 Medicare Part D claims per year.
What drugs does Arvind Cavale, M.D. prescribe most often? ▼
Based on 2023 Medicare Part D data, Arvind Cavale, M.D.'s most frequently prescribed drugs include Levothyroxine Sodium, Repaglinide, Trulicity. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Arvind Cavale, M.D. accept Medicare? ▼
Arvind Cavale, M.D. appears in CMS Medicare data with 7,021 Part D claims and 665 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Arvind Cavale, M.D.'s credentials? ▼
Arvind Cavale, M.D.'s NPI is 1457354581 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the PlainDoctor editorial team.